(Q28200286)

Nature Clinical Practice Rheumatology

inferred from title

coronary artery disease

1 reference

Michael Galindo

1

0 references

Lorinda Chung

series ordinal

2

0 references

Seth D Crockett

series ordinal

3

0 references

Eliza F Chakravarty

series ordinal

4

0 references

language of work or name

English

0 references

publication date

November 2005

0 references

published in

0 references

volume

1

0 references

page(s)

55-9; quiz 60

0 references

issue

1

0 references

cites work

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1038/NCPRHEUM0037

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

Meta-analysis of exercise testing to detect coronary artery disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

Statins: immunomodulators for autoimmune rheumatic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

Premature atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

7 January 2021

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

7 January 2021

Outcomes of coronary artery bypass grafting in patients with connective tissue diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

7 January 2021

Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0037

7 January 2021

release_463sherkujalvbgjslmaiothhe

Identifiers

DOI

10.1038/NCPRHEUM0037

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/463sherkujalvbgjslmaiothhe

24 November 2022